Yüklüyor......
Heparin dosing for percutaneous coronary angioplasty: Use of body surface area to improve initial activated clotting time values
Background: Activated clotting time (ACT) values during percutaneous transluminal coronary angioplasty (PTCA) after the initial 10,000 U heparin bolus are often below target values of 350 or 400 s (Hemochron) and have to be supplemented with additional heparin. This study evaluated the initial 10 mi...
Kaydedildi:
| Yayımlandı: | Clin Cardiol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley Periodicals, Inc.
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655856/ https://ncbi.nlm.nih.gov/pubmed/9422838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960201206 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|